We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBSB
551
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.67M | 0.02% |
161,372
-46,701
| -22% | -$529K |
|
|
EQC
552
DELISTED
Equity Commonwealth
EQC
| $1.67M | 0.02% |
62,668
-238,151
| -79% | -$7.36M |
|
553
PennyMac Financial
PFSI
$4.47B
| $1.66M | 0.02% |
+28,582
| New | +$1.42M |
|
554
Central Pacific Financial
CPF
$1.02B
| $1.65M | 0.02% |
121,791
-19,068
| -14% | -$289K |
|
555
Metallus
MTUS
$833M
| $1.63M | 0.02% |
458,053
-29,214
| -6% | -$112K |
|
556
Goosehead Insurance
GSHD
$2.51B
| $1.62M | 0.02% |
18,746
-968
| -5% | -$88.2K |
|
|
HOLX
557
DELISTED
Hologic
HOLX
| $1.62M | 0.02% |
24,336
-655
| -3% | -$41.5K |
|
|
CBAY
558
DELISTED
Cymabay Therapeutics
CBAY
| $1.61M | 0.02% |
222,608
-78,609
| -26% | -$420K |
|
559
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.61M | 0.02% |
58,976
-29,824
| -34% | -$882K |
|
560
New York Times
NYT
$12.6B
| $1.59M | 0.02% |
37,202
| – | – |
|
561
Great Southern Bancorp
GSBC
$878M
| $1.59M | 0.02% |
43,822
-9,804
| -18% | -$370K |
|
|
STEL
562
DELISTED
Stellar Bancorp
STEL
| $1.57M | 0.02% |
95,937
-6,958
| -7% | -$116K |
|
563
American Homes 4 Rent
AMH
$12.1B
| $1.57M | 0.02% |
55,012
+33,795
| +159% | +$954K |
|
|
MODN
564
DELISTED
MODEL N, INC.
MODN
| $1.56M | 0.02% |
44,173
-24,299
| -35% | -$918K |
|
565
Philip Morris
PM
$309B
| $1.56M | 0.02% |
20,744
+17,308
| +504% | +$1.34M |
|
566
Johnson & Johnson
JNJ
$640B
| $1.55M | 0.02% |
10,395
+2,701
| +35% | +$400K |
|
|
TPCO
567
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $1.53M | 0.02% |
131,587
+1,037
| +0.8% | +$11.1K |
|
568
Rambus
RMBS
$8.98B
| $1.53M | 0.02% |
111,750
+101,533
| +994% | +$1.44M |
|
569
Atara Biotherapeutics
ATRA
$72.6M
| $1.52M | 0.02% |
4,702
-430
| -8% | -$146K |
|
|
AZPN
570
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $1.52M | 0.02% |
12,000
-3,000
| -20% | -$380K |
|
571
Vera Bradley
VRA
$98.7M
| $1.52M | 0.02% |
248,307
+60,508
| +32% | +$323K |
|
|
JNCE
572
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.49M | 0.02% |
182,837
+2,089
| +1% | +$13K |
|
573
Polaris
PII
$3.83B
| $1.49M | 0.02% |
+15,808
| New | +$1.56M |
|
|
CAI
574
DELISTED
CAI International, Inc.
CAI
| $1.49M | 0.02% |
53,959
-1,356
| -2% | -$28.1K |
|
575
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $1.48M | 0.02% |
4,380
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.